GPBAR1 and fatty liver disease: Similarly, altered bile acid metabolism mediated by gut microbiota-derived EVs disrupts farnesoid X receptor (FXR) and Takeda G protein-coupled receptor 5 signaling (TGR5), contributing to hepatic steatosis and fibrosis [100].